Work

Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology

Year: 2012

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2012.04.046

Authors: Mark Ballow, Cezmi A. Akdis, Thomas B. Casale, Andrew J. Wardlaw, Sally E. Wenzel, Zuhair Ballas, Jan Lötvall

Institutions: University at Buffalo, State University of New York, University of Zurich, Creighton University, Glenfield Hospital, University of Pittsburgh, University of Pittsburgh Medical Center, University of Iowa, Iowa City VA Medical Center, University of Gothenburg

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Science Foundation, U.S. Department of Veterans Affairs, Amgen, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Teva Pharmaceutical Industries, CSL Behring, European Commission, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, European Academy of Allergy and Clinical Immunology, Grifols, National Institutes of Health, Genentech, Allergopharma

Awards: Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases, G7105628809, Mechanisms of the Development of ALLergy, G7409415364

OpenAlex ID: W2044830690

FWCI: 1.712

Cites: 133

Cited by: 17

Related to: 10